Originally from New Orleans, LA, Dr. Farria graduated from the University of California, Berkeley, earning a BS in Molecular Toxicology. She earned her Ph.D. at The University of Texas MD Anderson Center/UTHealth Houston Graduate School of Biomedical Sciences in the lab of Sharon Dent where she studied the role of the lysine acetyltransferase GCN5 in the formation and progression of B-cell lymphoma. Following her Ph.D., Dr. Farria was a postdoc in the lab of Kathryn Wellen at the University of Pennsylvania, studying the interface of acetyl-coA metabolism and epigenetic regulation. As a fellow in the NIH/IRACDA PennPORT program, Dr. Farria has taught classes at Delaware Community College and Lincoln University. Throughout her education and work experience, leadership and mentorship in Diversity and Inclusion have been persistent priorities.